Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
- Where
- Changchun, Harbin, Hefei, Shanghai, Wuhan
- Életkor
- 18 év and over
- People
- 54
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT06668103 - No phaseCsak meghívásosPlasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 500
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06730477 - No phaseTaking peopleGlycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 250
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06730503 - 2. fázisTaking peopleEfficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 32
- Run by
- Li-kun Chen
See details and how to joinNCT06728852 - No phaseTaking peopleThe Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 500
- Run by
- Sun Yat-sen University
See details and how to joinNCT06019455 - 2. fázisNot yet taking people in KínaA Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 120
- Run by
- Tasly Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06724263 - 2. fázisTaking peopleChemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 40
- Run by
- First People's Hospital of Hangzhou
See details and how to joinNCT06718309 - No phaseTaking peopleExploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 210
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT05598528 - No phaseTaking peopleMolecular Analysis and Treatment Options of SCLC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 500
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT05945745 - No phaseNot yet taking people in KínaMinimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
- Where
- Changsha, Chengdu, Dongguan, Foshan, Guangzhou, Guiyang, Nanjing, Nanning, Nantong, Shenzhen, Wuhan
- Életkor
- 18 év to 75 év
- People
- 342
- Run by
- Guangdong Association of Clinical Trials
See details and how to joinNCT06709274 - 2. fázisTaking peopleStudy of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
- Where
- Changsha, Guangzhou
- Életkor
- 18 év and over
- People
- 200
- Run by
- BeBetter Med Inc
See details and how to joinNCT06706713 - No phaseTaking peopleRadiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06648317 - 2. fázisTaking peopleCadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
- Where
- Changsha
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Rongrong Zhou
See details and how to joinNCT06702826 - 2. fázisTaking peopleEfficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 52
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06698965 - 1. fázisTaking peopleStudy of High Efficient Killing Cell Therapy for Advanced NSCLC
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 15
- Run by
- Ruijin Hospital
See details and how to joinNCT03193567 - No phaseTaking peoplePreoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Ruijin Hospital
See details and how to joinNCT04973293 - 1. fázisTaking peoplePropranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
- Where
- Changsha
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT05979818 - 2. fázisTaking peopleA Phase 2 Clinical Study of ABSK061 and ABSK043
- Where
- Changsha, Changzhi, Chengdu, Guiyang, Hangzhou, Harbin, Jinan, Nanchang, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Xiamen, Xi'an, Xiangyang, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 202
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT06632262 - 2. fázisTaking peopleNeoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression
- Where
- Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 29
- Run by
- Ruijin Hospital
See details and how to joinNCT06269211 - 1/2. fázisNot yet taking people in KínaA Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 30
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06690671 - 2. fázisNot yet taking people in KínaNeoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 30
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06688656 - No phaseCsak meghívásosPerioperative Treatment Outcomes of Early NSCLC
- Where
- Shanghai
- People
- 500
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06610240 - 1/2. fázisTaking peopleTIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
- Where
- Beijing
- Életkor
- 16 év to 90 év
- People
- 75
- Run by
- Essen Biotech
See details and how to joinNCT06532799 - No phaseTaking peopleAI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 800
- Run by
- Fudan University
See details and how to joinNCT06604689 - 2. fázisTaking peopleICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 27
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06388031